Cargando…
Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284163/ https://www.ncbi.nlm.nih.gov/pubmed/37351011 http://dx.doi.org/10.2147/IJGM.S425358 |
| _version_ | 1785061348156112896 |
|---|---|
| author | Shuja, Muhammad Hamza Khan, Muhammad Sohaib |
| author_facet | Shuja, Muhammad Hamza Khan, Muhammad Sohaib |
| author_sort | Shuja, Muhammad Hamza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10284163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102841632023-06-22 Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] Shuja, Muhammad Hamza Khan, Muhammad Sohaib Int J Gen Med Letter Dove 2023-06-17 /pmc/articles/PMC10284163/ /pubmed/37351011 http://dx.doi.org/10.2147/IJGM.S425358 Text en © 2023 Shuja and Khan. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Shuja, Muhammad Hamza Khan, Muhammad Sohaib Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] |
| title | Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] |
| title_full | Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] |
| title_fullStr | Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] |
| title_full_unstemmed | Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] |
| title_short | Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter] |
| title_sort | limitations in the use of cystatin c as a predictor of major adverse cardiovascular events: consideration of non-renal factors [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284163/ https://www.ncbi.nlm.nih.gov/pubmed/37351011 http://dx.doi.org/10.2147/IJGM.S425358 |
| work_keys_str_mv | AT shujamuhammadhamza limitationsintheuseofcystatincasapredictorofmajoradversecardiovasculareventsconsiderationofnonrenalfactorsletter AT khanmuhammadsohaib limitationsintheuseofcystatincasapredictorofmajoradversecardiovasculareventsconsiderationofnonrenalfactorsletter |